This relapsed DLBCL demonstrated drastic changes in both morphology (from immunoblastic to anaplastic) and immunophenotype (from non‐GCB to GCB), and gained expression of CD10, CD3 and CD5. This evidence concerns the gene MME and diffuse large B-cell lymphoma.